Study of YK012 in Primary Membranous Nephropathy

Clinical trial NCT06982729 · RECRUITING

Trial details

NCT number: NCT06982729
Sponsor: Excyte Biopharma Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Membranous Nephropathy

Start date: 2025-03-08
Primary completion: 2026-12-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.